The Quiet Death of the RAC

Until recently, the Recombinant DNA Advisory Committee (RAC) served as the country’s highest level review body for novel biotech research safety questions. But NIH disbanded it last year. That leaves, in most circumstances, the frequently dysfunctional local Institutional Biosafety Committees (IBCs) to be the first – and last – line of defense against really stupid ideas and screw ups.

Continue reading “The Quiet Death of the RAC”